• data-might-be-lost-due-to-device-failure
    Misconception #2 on eCOA barriers: Data might be lost due to device failure
    16 January 2020

    The fear of losing data is more than… | Read More

  • patient-training-and-retraining-plan
    Misconception #1 on eCOA barriers: Patient training and re-training plan is a burden
    13 December 2019

    As “end users “of innovative technologies, site staff… | Read More

  • estelle-haenel-video
    Are barriers to eCOA adoption true hurdles?
    12 December 2019

    Over recent years, as an industry, we seem… | Read More

  • man-woman-laptop
    Switching to digital: why will it help clinical trials stakeholders?
    19 November 2019

    The decline in R&D efficiency is one of… | Read More

  • applied-clinical-trials
    eCOA Back-up Solutions: Perception vs Reality
    12 November 2019

    Digital solutions have without a doubt improved both… | Read More

  • press-release-kayentis-opens-japanese-subsidiary
    Press Release // Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector
    5 November 2019

    Proximity will facilitate local and international sponsor access… | Read More

  • patient
    How can digital innovation turn clinical trials into a positive patient and site experience?
    31 October 2019

    Digital innovation is increasingly penetrating the healthcare industry… | Read More

  • Associations
    Kayentis gives back to its community by donating to two local associations
    8 October 2019

    Aware of its responsibility towards the environment, Kayentis… | Read More

  • Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium
    26 September 2019

    Kayentis announces that it has joined the C-Path’s… | Read More

  • eCOA study: Paper back-up and data reliability
    16 September 2019

    eCOA study: the impact of a paper back-up… | Read More

  • press-release
    Press Release // Kayentis appoints Estelle Haenel as medical director
    3 September 2019

    25-year pharma industry veteran and clinical trials expert… | Read More

  • Inclusion and gender diversity is not a given!
    26 August 2019

    This can only be the result of a… | Read More

  • 2018 Employee Satisfaction Survey
    29 July 2019

    The results are in! 2018 was marked by… | Read More

  • aligning objectives ecoa vendor
    The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study
    25 July 2019

    Any enduring business relationship between a service provider… | Read More

  • Including eCOA in a clinical trial in China
    16 July 2019

    With a large patient pool and growing pharma… | Read More

  • Kayentis supports the 1st personalized immunotherapy treatment approved by both FDA & CHMP
    9 July 2019

    Acute Lymphoblastic or Lymphoid Leukemia (ALL) is a… | Read More

  • Six reasons to work at Kayentis
    11 June 2019

    Here are 6 reasons to knock at our… | Read More

  • Estelle Haenel, Kayentis’ Medical Director
    Kayentis welcomes Estelle Haenel, PharmD, PhD, as Medical Director
    10 May 2019

    Estelle Haenel has joined Kayentis as Medical Director…. | Read More

  • Waste Management Report 2018
    12 March 2019

    Kayentis is committed to responsible waste management After… | Read More

  • Implementing Kayentis Spirit in the US, a key challenge for Kayentis team
    4 March 2019

    Interview with Björn Felber – Project Director, Kayentis… | Read More


  • 26 October
    OCT Europe 2020 - October 26-27 - Paris, France - Booth #83 - Schedule a meeting with Kayentis
  • 02 November
    Clinical Trials Europe - Nov 2-4 - Amsterdam, The Netherlands - Booth #88 - Schedule a meeting with Kayentis     Clinical Trials Europe
  • 08 November
    DIA Japan - Nov 8-10 - Tokyo Big Sight, Ariake - Booth #17 -  Schedule a meeting with Kayentis
  • Follow us